Fundraising Fox

Metcela

4 known investors

Metcela develops cell-based medicines through research and development, focused on delivering new treatments for children and people affected by rare diseases.

BiotechMedical Devices

Investors · 4

Beyond Next VenturesTokyo
F-Prime CapitalCambridge · $3M – $10M
OSAKA University Venture CapitalOsaka · $3M – $142M
Sony Ventures CorporationTokyo

In the news

Metcela Eligible to Receive up to $7 Million (1 Billion JPY) AMED Grant for Promoting the Development of Regenerative Medicine Product Using Cardiac Stem Cells | Metcela Inc.metcela.com · Nov 2022Metcela Closes $14M Series C Financing - FinSMEsfinsmes.com · Jul 2022Metcela Inc. Completes the Series C Financing of Total $14 Million | Metcela Inc.metcela.com · Jun 2022Metcela Raises $12.7M in Series B Financing - FinSMEsfinsmes.com · Jan 2021Metcela Raised $4 Million in Series B Funding to Launch a Phase I Clinical Trial for Heart Failure Therapy | Metcela Inc.metcela.com · May 2020Metcela raises 520 million yen in Series A financing round | Metcela Inc.metcela.com · Sep 2018

Frequently asked questions

What does Metcela do?
Metcela develops cell-based medicines through research and development, focused on delivering new treatments for children and people affected by rare diseases.
Who are Metcela's investors?
Metcela's investors include Beyond Next Ventures, F-Prime Capital, OSAKA University Venture Capital, Sony Ventures Corporation.